enVVeno Medical

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$824
Gross Profit
-136
-141
690
EBITDA
-5,318
-5,362
-6,144
EBIT
-5,454
-5,503
-6,278
Net Income
-4,956
-4,992
-5,649
Net Change In Cash
0
0
824
Free Cash Flow
-3,922
-3,559
-4,977
Cash
2,380
2,314
3,620
Basic Shares
16,067
16,056
13,317

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-546
-525
-452
-383
EBITDA
-25,018
-24,509
-16,753
-8,751
EBIT
-25,238
-25,034
-17,205
-9,135
Net Income
-23,516
-24,304
-16,196
-8,919
Net Change In Cash
0
0
0
0
Cost of Revenue
-50,173
Free Cash Flow
-18,891
-15,734
-12,213
-7,857
Cash
3,620
4,555
54,727
9,334
Basic Shares
12,301
11,230
8,679
1,291

Earnings Calls

Quarter EPS
2024-09-30
-$0.35
2024-06-30
-$0.31
2024-03-31
-$0.31
2023-12-31
-$0.36